CD8A and neoplasm: Given that increasing numbers of tumor infiltrating CD8+ T-cells cells are associated with better prognosis and response to immunotherapy, work aimed at promoting T-cell infiltration into the tumor (core) could help improve patient outcomes as well as sensitize them to already approved immunotherapies.